0001795304-19-000002.txt : 20191127 0001795304-19-000002.hdr.sgml : 20191127 20191127162156 ACCESSION NUMBER: 0001795304-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191127 DATE AS OF CHANGE: 20191127 EFFECTIVENESS DATE: 20191127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PDX Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001795304 IRS NUMBER: 843790146 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-354434 FILM NUMBER: 191258185 BUSINESS ADDRESS: STREET 1: 3303 SW BOND AVENUE, CH13B CITY: PORTLAND STATE: OR ZIP: 97239 BUSINESS PHONE: 503-418-9306 MAIL ADDRESS: STREET 1: 3303 SW BOND AVENUE, CH13B CITY: PORTLAND STATE: OR ZIP: 97239 D 1 primary_doc.xml X0708 D LIVE 0001795304 PDX Pharmaceuticals, Inc. 3303 SW BOND AVENUE, CH13B PORTLAND OR OREGON 97239 503-418-9306 OREGON PDX Pharmaceuticals, LLC None Corporation true Wassana Yantasee 3303 SW BOND AVENUE, CH13B PORTLAND OR OREGON 97239 Executive Officer Director Worapol Ngamcherdtrakul 3303 SW BOND AVENUE, CH13B PORTLAND OR OREGON 97239 Executive Officer Joe Gray 3303 SW BOND AVENUE, CH13B PORTLAND OR OREGON 97239 Director Angela Hult 3303 SW BOND AVENUE, CH13B PORTLAND OR OREGON 97239 Director Biotechnology Decline to Disclose 06b false 2019-11-18 true true false 0 4049923 1550000 2499923 false 2 0 0 0 false PDX Pharmaceuticals, Inc. /s/ Wassana Yantasee Wassana Yantasee President and CEO 2019-11-27